Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Postmenopausal hormone therapy: who now takes it and do they differ from non-users?

Anne W Taylor1, Alastair H MacLennan, Jodie C Avery

  • 1Population Research and Outcome Studies, South Australian Department of Health, Adelaide, South Australia. anne.taylor@health.sa.gov.au

The Australian & New Zealand Journal of Obstetrics & Gynaecology
|April 28, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Female sexual dysfunction among foreign and Australian-born women: a cross-sectional study.

Frontiers in reproductive health·2026
Same author

Healthcare providers' approaches to sexual function in women with migration histories: a qualitative study using Andersen's behavioural model.

International journal for equity in health·2026
Same author

Testing the performance of polygenic scores for multiple traits to explain cerebral palsy in two independent cohorts.

EBioMedicine·2026
Same author

Burdens and risk factors for mortality in adolescents and young adults aged 10-24 years in Australia and comparison with OECD countries between 2000 and 2021: Global Burden of Disease Study 2021.

BMJ public health·2025
Same author

Global trends in the uptake of specialist diagnostic ultrasound and MRI scans for endometriosis: An international cross-sectional survey.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2025
Same author

Genetic diagnostic yield by MRI pattern in children with cerebral palsy: a population-based study.

EBioMedicine·2025

Postmenopausal hormone therapy use has changed significantly. Current users and non-users show no major differences in health, except for menopausal symptoms, suggesting better patient selection is needed.

Area of Science:

  • Reproductive Medicine
  • Public Health
  • Epidemiology

Background:

  • Hormone therapy (HT) use among postmenopausal women has seen significant shifts.
  • Understanding current trends and user characteristics is crucial for informed clinical practice.

Purpose of the Study:

  • To determine current postmenopausal hormone therapy usage patterns.
  • To analyze trends and changes in HT usage over 13 years.
  • To compare health and risk factors between HT users and non-users.

Main Methods:

  • Utilized data from an annual population health survey of South Australians (eight times since 1991).
  • Included specific questions on HT use, health status, and quality of life in 2004.
  • Analyzed demographic, health-related, and lifestyle variables.

Related Experiment Videos

Main Results:

  • In 2004, 15.4% of women over 40, 19.8% over 50, and 31.2% aged 50-59 used HT.
  • Ever-use among women over 50 was 46.5%, with an average duration of 7.46 years.
  • Users and non-users showed no significant differences in chronic disease, BMI, complementary medicine use, socioeconomic status, or quality of life.
  • Increased HT use correlated with higher income, education, employment, and marital status in women in their 50s.
  • HT use increased until 2000, then declined in 2003 and 2004.

Conclusions:

  • No evidence supports differences in quality of life or health characteristics between HT users and non-users, apart from menopausal symptoms.
  • Highlights the need for more appropriate selection criteria for women considering hormone therapy.
  • Current trends indicate a recent decline in hormone therapy usage.